Indirect Buyers Decertified In Wellbutrin Pay-For-Delay Suit
The Pennsylvania federal judge overseeing pay-for-delay litigation against GlaxoSmithKline PLC and others over the antidepressant Wellbutrin XL decertified the class of indirect purchasers on Tuesday, saying it has failed to carry...To view the full article, register now.
Already a subscriber? Click here to view full article